Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impending rupture in the apparent healing phase after chimney endovascular aneurysm repair for a Bacillus Calmette-Guérin-related paravisceral infective aortic aneurysm.

Journal of vascular surgery cases and innovative techniques·2026
Same author

Consensus Statement on the Timing of Median Arcuate Ligament Release in Patients With Pancreaticoduodenal or Gastroduodenal Artery Aneurysms Associated With Median Arcuate Ligament Syndrome.

Asian journal of endoscopic surgery·2026
Same author

Management of Median Arcuate Ligament Compression in Patients Undergoing Pancreaticoduodenectomy: A Systematic Review and Consensus Statements.

Asian journal of endoscopic surgery·2026
Same author

Consensus Statement on Precision Anatomy and Treatment Strategies for Median Arcuate Ligament Syndrome: AOB Consensus Meeting.

Asian journal of endoscopic surgery·2025
Same author

Optimal D-dimer value for acute deep vein thrombosis screening in the lower limb in cases with carcinomas.

Medicine·2025
Same author

Outcomes of Endovascular Repair for Infected Native Thoracic Aortic Aneurysms: A Japanese Multicentre Study.

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery·2025

Related Experiment Video

Updated: Jul 16, 2026

Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation
09:32

Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation

Published on: September 19, 2018

15.3K

A Multifaceted Approach to Abdominal Aortic Aneurysm.

Katsuyuki Hoshina1

  • 1Department of Vascular Surgery, The University of Tokyo, Tokyo, Japan.

Annals of Vascular Diseases
|January 29, 2025
PubMed
Summary

Researchers explored abdominal aortic aneurysms (AAAs) using rat models and nanoparticle delivery. They analyzed endovascular aneurysm repair (EVAR) data, particularly in Japan, to improve treatment evidence.

Keywords:
Japanese Committee for Stentgraft Managementabdominal aortic aneurysmexperimental study: registry: clinical questionhemodynamicsimulation

More Related Videos

Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta
07:12

Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta

Published on: September 8, 2023

2.2K
Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm
05:07

Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm

Published on: August 2, 2024

746

Related Experiment Videos

Last Updated: Jul 16, 2026

Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation
09:32

Manufacturing Abdominal Aorta Hydrogel Tissue-Mimicking Phantoms for Ultrasound Elastography Validation

Published on: September 19, 2018

15.3K
Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta
07:12

Author Spotlight: Using Point-of-Care Ultrasound for Comprehensive Evaluation of the Abdominal Aorta

Published on: September 8, 2023

2.2K
Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm
05:07

Author Spotlight: Development and Characterization of a Mouse Model for Abdominal Aortic Aneurysm

Published on: August 2, 2024

746

Area of Science:

  • Vascular Surgery
  • Biomedical Engineering
  • Nanotechnology

Background:

  • Abdominal aortic aneurysms (AAAs) mechanisms remain incompletely understood.
  • Multifactorial AAA development necessitates comprehensive research approaches.

Purpose of the Study:

  • Investigate AAA mechanisms using novel models and drug delivery systems.
  • Evaluate the clinical evidence for endovascular aneurysm repair (EVAR), especially in Japan.
  • Generate evidence for clinical practice through medical-engineering collaboration.

Main Methods:

  • Development of an elastase-infused rat AAA model.
  • Application of nanoparticle drug delivery systems.
  • Analysis of extensive EVAR registry data, including the Japanese Committee for Stent Graft Management.
  • Utilization of simulation methods for clinical question resolution.

Main Results:

  • Established a robust preclinical model for AAA research.
  • Initiated nanoparticle-based therapeutic strategies for AAA.
  • Provided crucial data on EVAR outcomes and trends in Japan.
  • Generated simulation-based evidence to support clinical decision-making.

Conclusions:

  • The study advanced understanding of AAA pathophysiology and treatment.
  • Nanoparticle drug delivery shows promise for AAA management.
  • EVAR evidence in Japan was significantly enhanced, informing clinical practice.